The baronial affiliate of the House Energy and Commerce Committee is aggressive answers afterwards added than 17,000 barter complained about beard accident afterwards application WEN haircare products.
Rep. Frank Pallone Jr.Frank Joseph PalloneDems eye aggressive calendar if House flips Hillicon Valley: Facebook breach over exec’s abutment for Kavanaugh | Dem afraid about Russian trolls jumping into Kavanaugh agitation | China pushes aback on Pence House Democrat questions big tech on accessible adopted admission in Kavanaugh agitation MORE (D-N.J.) this anniversary beatific belletrist to both the Food and Drug Administration (FDA) and Georg Richter, the admiral and CEO of the product’s manufacturer, allurement why consumers are accusatory about cogent beard loss, arresting baldheaded spots, beard accident and attic irritation. One chump appear that they connected to lose beard for three weeks afterwards they had chock-full application the product.
“Consumers deserve to apperceive that they are authoritative safe choices aback they acquirement cosmetics,” Pallone said in a account release. “Unfortunately, aback accepted cosmetics and claimed affliction articles are abundantly able afore they ability the marketplace, these articles can accommodate adverse chemicals that accept the abeyant to put consumers at risk.”
The product’s manufacturer, Guthy-Renker LLC, has reportedly denied any assurance issues associated with its cleansing conditioner admitting customer complaints that date aback to 2008.
In his letter to Richter, Pallone requested a conference with staffers “as anon as possible.” He additionally requested copies of commissioned assessments, abstracts accompanying to artefact testing, a abundant timeline of the company’s interactions and communications with the FDA and all communications from the aggregation apropos to the abeyant ancillary furnishings or assurance issues with WEN products.
Pallone asked the FDA aback and how it aboriginal became acquainted of the assurance issues associated with WEN Cleaning Conditioner, what steps, if any, it took to abode those issues and what advice Guthy-Renker has aggregate with the agency.
Pallone additionally wants to apperceive whether the FDA had admission to any of the company’s assurance records, if it has conducted any inspections, if the bureau has requested a artefact anamnesis and if the bureau has acceptable ascendancy now to baby-sit the product.